Eli Lilly Co Drug Patent Portfolio

Eli Lilly Co's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Eli Lilly Co News

Eli Lilly's $1 Billion Investment in Genetic Therapies - AD HOC NEWS

29 Jan, 2026

Eli Lilly Allocates Billions to Expand Beyond Major Pharmaceutical Products

29 Jan, 2026

Lilly Enters into Smooth Gene-Editing Agreement Worth More Than $1.1 Billion - Bloomberg

28 Jan, 2026

Lawsuits claim significant side effects from GLP-1 weight-loss medications - USA Today

28 Jan, 2026

See More